Abel Suárez-Castro is a researcher and academic in the health sciences, with a background in pharmaceutical chemistry and biomedical research. His work focuses on computer-aided drug design, molecular docking, and in silico approaches for the identification of bioactive compounds, particularly against antimicrobial resistance mechanisms. His research interests include drug–target interactions, efflux pump inhibition, pharmacokinetic and ADMET prediction, and the exploration of natural product-derived compounds as potential therapeutic agents. He has experience working with molecular modeling platforms and virtual screening tools applied to infectious diseases and metabolic disorders. In parallel, he is actively involved in teaching and academic coordination in medicine and nutrition programs, with a strong interest in translational research, scientific rigor, and the responsible integration of artificial intelligence into biomedical research and education.